7-amino-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ol
1 paper4 findings
- 1 lab in 1 country
- Funders: National Natural Science Foundation of China and 1 more
- Cells1
Outcomes
4mTOR signalling
upin human cells1
1 study
mTOR signalling
upin human cells1
7-amino-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ol activates mTOR signalling in human cells.
“We found that ABO decreased AMPK phosphorylation and increased the phosphorylation level and activity of mTOR.”
Cellsdermis
Journal of cellular biochemistrySep 8, 2023
AMPK signalling
downin human cells1
1 study
AMPK signalling
downin human cells1
7-amino-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ol inhibits AMPK signalling in human cells.
“We found that ABO decreased AMPK phosphorylation and increased the phosphorylation level and activity of mTOR.”
Cellsdermis
Journal of cellular biochemistrySep 8, 2023
Cellular senescence
downin human cells1
1 study
Cellular senescence
downin human cells1
7-amino-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ol inhibits cellular senescence in human cells.
“As a result, ABO inhibited the senescence of human dermal fibroblasts (HDFs).”
Cellsdermis
Journal of cellular biochemistrySep 8, 2023
Chromatin and 3D genome organisation
downin human cells1
1 study
Chromatin and 3D genome organisation
downin human cells1
7-amino-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-ol inhibits chromatin and 3D genome organisation in human cells.
“found 7-amino-2,3,4,5-tetrahedrobenzo[b][1,4] oxazepin-3-ol (ABO) that was identified as an inhibitor of annexin A7 GTPase (ANXA7) dramatically suppressed the aggregation of heterochromatin protein (HP1γ)”
Cellsdermis
Journal of cellular biochemistrySep 8, 2023